Seasoned Leaders in the Field

Our team

We are an exceptional team of leaders committed to driving transformative advancements in drug development.

Leadership

Peter Ding

Chief Executive Officer

Fang Li, Ph.D. 

Chief Scientific Officer

Gregory Berk, M.D. 

Chief Medical Officer

Scientific Advisory Board

Nathanael Gray, Ph.D.,

Professor,
Stanford University,
Scientific founder

Pasi Jänne, M.D., Ph.D.,

Professor,
Dana Farber Cancer Institute
Harvard Medical School

Kwok-Kin Wong, M.D., Ph.D.,

Professor,
NYU Medical School

Xu Wu, Ph.D.

Associate Professor,
Massachusetts General Hospital